NEW YORK & TONGHUA, China--(BUSINESS WIRE)--BioPharm Asia, Inc.(OTCBB: BFAR; the “Company”) announced today that its newly-acquired subsidiary, Beijing Zhihe Ruikang Hospital Management Ltd. (“ZHRK”), is negotiating to acquire a controlling interest in Shandong Weifang Municipal Hospital (“WFMH”).
